Matteo Monieri

546 total citations
15 papers, 432 citations indexed

About

Matteo Monieri is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Matteo Monieri has authored 15 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Biomaterials. Recurrent topics in Matteo Monieri's work include Nanoparticle-Based Drug Delivery (4 papers), Cell Adhesion Molecules Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Matteo Monieri is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Cell Adhesion Molecules Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Matteo Monieri collaborates with scholars based in Italy, Germany and United States. Matteo Monieri's co-authors include Fabio Corsi, Marta Truffi, Serena Mazzucchelli, Luca Sorrentino, Luisa Fiandra, Pietro Zerbi, Gianluca M. Sampietro, Angelina Sacchi, Davide Prosperi and Angelo Corti and has published in prestigious journals such as Nature Communications, Cancer Research and Chemical Communications.

In The Last Decade

Matteo Monieri

15 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matteo Monieri Italy 10 176 135 102 85 80 15 432
Quanwei Shi China 11 177 1.0× 121 0.9× 170 1.7× 52 0.6× 86 1.1× 15 430
Zeyad Nasa Australia 13 140 0.8× 79 0.6× 69 0.7× 40 0.5× 47 0.6× 21 538
Aviva C. Krauss United States 9 155 0.9× 113 0.8× 89 0.9× 159 1.9× 118 1.5× 20 442
Minqiang Xie China 14 257 1.5× 181 1.3× 145 1.4× 22 0.3× 132 1.6× 42 646
Vicenta Trujillo-Alonso United States 7 182 1.0× 67 0.5× 104 1.0× 54 0.6× 116 1.4× 7 481
Eva Golunski United States 9 261 1.5× 81 0.6× 97 1.0× 18 0.2× 78 1.0× 15 568
Christopher D. Sarsons Canada 8 220 1.3× 182 1.3× 163 1.6× 29 0.3× 30 0.4× 15 485
Eric M. Mastria United States 8 149 0.8× 236 1.7× 153 1.5× 17 0.2× 44 0.6× 12 499
Xiangshi Sun China 13 279 1.6× 161 1.2× 233 2.3× 32 0.4× 90 1.1× 17 631
Chenglong Ge China 13 366 2.1× 137 1.0× 158 1.5× 21 0.2× 32 0.4× 27 649

Countries citing papers authored by Matteo Monieri

Since Specialization
Citations

This map shows the geographic impact of Matteo Monieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Monieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Monieri more than expected).

Fields of papers citing papers by Matteo Monieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Monieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Monieri. The network helps show where Matteo Monieri may publish in the future.

Co-authorship network of co-authors of Matteo Monieri

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Monieri. A scholar is included among the top collaborators of Matteo Monieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Monieri. Matteo Monieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Citro, Antonio, Cataldo Pignatelli, Matteo Monieri, et al.. (2023). Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes. Nature Communications. 14(1). 878–878. 24 indexed citations
2.
Monieri, Matteo, Angelina Sacchi, Alessandro Gori, et al.. (2022). A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins. International Journal of Biological Sciences. 19(1). 156–166. 6 indexed citations
3.
Alchera, Elisa, Matteo Monieri, Mirko Maturi, et al.. (2022). Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics. 28. 100400–100400. 25 indexed citations
4.
Sacchi, Angelina, Anna Maria Gasparri, Matteo Monieri, et al.. (2021). Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting. Frontiers in Chemistry. 9. 690357–690357. 2 indexed citations
5.
Corti, Angelo, Angelina Sacchi, Anna Maria Gasparri, et al.. (2021). Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold. Journal of Nanobiotechnology. 19(1). 128–128. 16 indexed citations
6.
Truffi, Marta, Marta Sevieri, Lucia Morelli, et al.. (2020). <p>Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease</p>. International Journal of Nanomedicine. Volume 15. 8537–8552. 15 indexed citations
7.
Andreata, Francesco, Arianna Bonizzi, Marta Sevieri, et al.. (2020). Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Scientific Reports. 10(1). 11425–11425. 19 indexed citations
8.
Corti, Angelo, Anna Maria Gasparri, Angelina Sacchi, et al.. (2020). NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity. Molecular Pharmaceutics. 17(10). 3813–3824. 9 indexed citations
9.
Salvioni, Lucia, Francesco Andreata, Matteo Monieri, et al.. (2020). Nanoparticle‐Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment. Advanced Therapeutics. 3(8). 5 indexed citations
10.
Nardelli, Francesca, Michela Ghitti, Giacomo Quilici, et al.. (2019). A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8. Chemical Communications. 55(98). 14777–14780. 8 indexed citations
11.
Colombo, Miriam, Maria Antonietta Rizzuto, Laura Pandolfi, et al.. (2018). Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer. Bioconjugate Chemistry. 29(11). 3817–3832. 15 indexed citations
12.
Truffi, Marta, Matteo Monieri, Luca Sorrentino, et al.. (2018). Abstract P1-10-11: Multivalent exposure of trastuzumab on iron oxide nanoparticles enhances antitumor activity and weakens drug resistance in HER2+ breast cancer cells. Cancer Research. 78(4_Supplement). P1–10. 2 indexed citations
13.
Truffi, Marta, Luca Sorrentino, Matteo Monieri, et al.. (2018). Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn’s Disease Strictures Ex Vivo. Inflammatory Bowel Diseases. 24(2). 332–345. 51 indexed citations
14.
Truffi, Marta, Miriam Colombo, Luca Sorrentino, et al.. (2017). Nano-Targeting of Mucosal Addressin Cell Adhesion Molecule-1 Identifies Bowel Inflammation Foci in Murine Model. Nanomedicine. 12(13). 1547–1560. 13 indexed citations
15.
Truffi, Marta, Luisa Fiandra, Luca Sorrentino, et al.. (2016). Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer. Pharmacological Research. 107. 57–65. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026